Submitted: 20 Feb 2019
Revised: 03 Jul 2019
Accepted: 04 Jul 2019
First published online: 06 Aug 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Health Promot Perspect. 2019;9(3):214-222.
doi: 10.15171/hpp.2019.30
  Abstract View: 12
  PDF Download: 28

Original Article

Do drug package inserts meet the rules and regulations of Iran’s Food and Drug Administration in terms of informing patients?

Tahereh Eteraf-Oskouei 1 ORCiD, Saeid Abdollahpour 1 ORCiD, Moslem Najafi 1 ORCiD, Vahideh Zarea 1,2 *

1 Department of Pharmacology & Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
2 Department of Medical Library and information Science, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran
3 Tabriz Health Services Management Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Abstract

Background: Drug package inserts (PIs) are the most accessible source of information for users and are designed to aid the safe use of medicines and avert adverse events. This study measured the conformity of PIs with the health communications standards of Iran’s Food and drug Administration (FDA). Methods: This descriptive cross-sectional study evaluated 92 PIs related to 22 best-selling neurological and psychiatric drugs in Iran based on criteria approved by Iran’s FDA. Six categories of criteria were considered in evaluating the extent of conformity: I) writing and formatting, II) references, III) drug description, IV) warnings and precautions, V) interactions, and VI) side effects. Each PI was scored based on observation of standards; data was analyzed using Microsoft Excel pivot tables. Results: In total, 2929 items from 92 PIs were evaluated, of which 37 (40.2%) were related to antidepressants, 31 (33.7%) to sedatives and hypnotics, and 24 (26%) to anticonvulsant drugs. The PI content was insufficient in various aspects of conformity with standards in each category. Among the six categories, the best match was found in warnings and precautions with 667items (72.5%), followed by writing and formatting with 663 (69.1%). The lowest conformity was found in the reference category with 194 (26.4%) items. Conclusion: The PIs of Iranian neurological drugs do not fully meet Iran’s FDA standards. It is strongly recommended that smart PIs be developed using mobile apps to overcome this problem.
Citation: Eteraf-Oskouei T, Abdollahpour S, Najafi M, Zarea Gavgani V. Do drug package inserts meet the rules and regulations of Iran’s Food and Drug Administration in terms of informing patients? Health Promot Perspect. 2019;9(3):214-222. doi: 10.15171/hpp.2019.30.
First name
 
Last name
 
Email address
 
Comments
 
Security code


Article Viewed: 12

Your browser does not support the canvas element.


PDF Downloaded: 28

Your browser does not support the canvas element.